Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

Keyphrases

• Population Pharmacokinetics 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Infected Individual 100%
• Nevirapine 100%
• Pharmacokinetics 50%
• Plasma Concentration 25%
• Aspartate Aminotransferase 25%
• Patient Characteristics 16%
• Outpatient Clinic 16%
• Chronic HCV Infection 16%
• Inter-individual Variability 8%
• NONMEM 8%
• Volume of Distribution 8%
• Patient Demographics 8%
• Blood Samples 8%
• Population Pharmacokinetic Model 8%
• Pharmacokinetic Parameters 8%
• Interoccasion Variability 8%
• First-order 8%
• Serology 8%
• Concomitant Use 8%
• Clinical Chemistry 8%
• Total Bilirubin 8%
• Liver Enzymes 8%
• Upper Normal Limit 8%
• HIV Patients 8%
• Chronic HCV 8%
• Residual Variability 8%
• Hepatitis B 8%
• HCV Virus 8%
• St. John's Wort 8%
• Absorption Rate Constant 8%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Nevirapine 100%
• Pharmacokinetics 100%
• Aspartate Aminotransferase 25%
• Infection 16%
• Volume of Distribution 8%
• NONMEM 8%
• Pharmacokinetic Parameter 8%
• Elimination 8%
• Bilirubin 8%
• Liver Enzyme 8%
• Hepatitis B Virus 8%
• Hypericum perforatum 8%
• Hepatitis B 8%
• Hepatitis C Virus 8%